Generali Asset Management
BIIB icon

Generali Asset Management’s Biogen BIIB Stock Holding History

Generali Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.36M Buy
36,993
+1,619
+5% +$343K 0.15% 137
2026
Q2 		$7.64M Buy
35,374
+1,180
+3% +$226K 0.14% 143
2026
Q1 		$6.27M Buy
34,194
+7,013
+26% +$1.29M 0.13% 153
2025
Q4 		$4.78M Sell
27,181
-13,744
-34% -$2.25M 0.1% 193
2025
Q3 		$5.73M Sell
40,925
-757
-2% -$102K 0.12% 160
2025
Q2 		$5.23M Buy
41,682
+2,518
+6% +$314K 0.12% 171
2025
Q1 		$5.36M Buy
39,164
+22,969
+142% +$3.28M 0.13% 168
2024
Q4 		$2.48M Buy
+16,195
New +$2.73M 0.06% 288

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Nippon Life Global Investors Americas
Nippon Life Global Investors Americas New York $2.51B AUM 38.65% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Adams Diversified Equity Fund
Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return

Generali Asset Management's BIIB Position: Q3 2026 in Review

Generali Asset Management increased its Biogen (BIIB) stake by 4.6% in Q3 2026, buying an estimated $343K and bringing the position to 36,993 shares worth $8.36M. The position accounts for 0.15% of the portfolio, ranked #137.

Generali Asset Management first reported a position in BIIB in Q4 2024 and has held it in 8 quarters since. 335 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Generali Asset Management held 36,993 shares of Biogen worth $8.36M as of Q3 2026.
  • Generali Asset Management bought 1,619 Biogen shares in Q3 2026, an estimated $343K.
  • Biogen made up 0.15% of Generali Asset Management's portfolio in Q3 2026, its #137 holding.
  • Generali Asset Management first reported a position in Biogen in Q4 2024 and has held it in 8 quarters since.
  • 335 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.